Interactions of murine gammaherpesvirus 68 with B and T cell lines

N P Sunil-Chandra1, S Efstathiou, A A Nash

  • 1Department of Pathology, University of Cambridge, United Kingdom.

Virology
|April 1, 1993
PubMed

Insights

Murine gammaherpesvirus (MHV-68) establishes persistent infections in mouse myeloma cells, not T cells. This provides an in vitro model for studying MHV-68 latency and persistence in B lymphocytes.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Murine gammaherpesvirus (MHV-68) is a natural pathogen of wild rodents.
  • In vivo, MHV-68 establishes a latent infection primarily within B lymphocytes, similar to Epstein-Barr virus.
  • Understanding the mechanisms of gammaherpesvirus latency is crucial for developing antiviral strategies.

Purpose of the Study:

  • To establish an in vitro model for studying MHV-68 latency and persistence.
  • To investigate the cellular tropism of MHV-68 in vitro.
  • To analyze the impact of antiviral treatment on viral DNA forms during persistent infection.

Main Methods:

  • Establishing persistent MHV-68 infection in mouse myeloma (NSO) and thymoma (BW 5147) cell lines.
  • Assessing viral persistence and production using infectious center assays.
  • Analyzing viral DNA forms (linear and circular genomes) using molecular techniques.
  • Treating infected cells with acyclovir (ACV) to evaluate its effect on productive infection and viral DNA.

Main Results:

  • MHV-68 established a persistent infection in mouse myeloma (B) cells but not in thymoma (T) cells.
  • The virus persisted indefinitely in myeloma cells without significant cytopathic effect, producing infectious virions.
  • Acyclovir (ACV) treatment abolished productive infection, but latent viral genomes remained detectable.
  • During persistent infection, linear viral genomes predominated, with low levels of circular DNA; ACV reduced linear genomes but not circular DNA.

Conclusions:

  • Mouse myeloma cells provide a suitable in vitro model for studying MHV-68 latency.
  • B lymphocytes are confirmed as the primary site for MHV-68 latency.
  • The differential effect of ACV on linear and circular viral DNA suggests distinct roles in viral persistence.